The diagnosis of clinically suspected venous thrombosis. 1984

R D Hull, and G E Raskob, and J R LeClerc, and R M Jay, and J Hirsh

The clinical diagnosis of venous thrombosis is highly non-specific. The reason for this is that none of the symptoms or signs of venous thrombosis is unique to this condition--that is, each can be caused by nonthrombotic disorders. Objective testing to confirm or exclude the diagnosis of venous thrombosis, then, is mandatory in patients with clinically suspected deep vein thrombosis.

UI MeSH Term Description Entries
D007457 Iodine Radioisotopes Unstable isotopes of iodine that decay or disintegrate emitting radiation. I atoms with atomic weights 117-139, except I 127, are radioactive iodine isotopes. Radioisotopes, Iodine
D010690 Phlebography Radiographic visualization or recording of a vein after the injection of contrast medium. Venography,Phlebographies,Venographies
D010992 Plethysmography, Impedance Recording changes in electrical impedance between electrodes placed on opposite sides of a part of the body, as a measure of volume changes in the path of the current. (Stedman, 25th ed) Rheography,Impedance Plethysmography,Impedance Plethysmographies,Plethysmographies, Impedance,Rheographies
D011877 Radionuclide Imaging The production of an image obtained by cameras that detect the radioactive emissions of an injected radionuclide as it has distributed differentially throughout tissues in the body. The image obtained from a moving detector is called a scan, while the image obtained from a stationary camera device is called a scintiphotograph. Gamma Camera Imaging,Radioisotope Scanning,Scanning, Radioisotope,Scintigraphy,Scintiphotography,Imaging, Gamma Camera,Imaging, Radionuclide
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D003362 Cost-Benefit Analysis A method of comparing the cost of a program with its expected benefits in dollars (or other currency). The benefit-to-cost ratio is a measure of total return expected per unit of money spent. This analysis generally excludes consideration of factors that are not measured ultimately in economic terms. In contrast a cost effectiveness in general compares cost with qualitative outcomes. Cost and Benefit,Cost-Benefit Data,Benefits and Costs,Cost Benefit,Cost Benefit Analysis,Cost-Utility Analysis,Costs and Benefits,Economic Evaluation,Marginal Analysis,Analyses, Cost Benefit,Analysis, Cost Benefit,Analysis, Cost-Benefit,Analysis, Cost-Utility,Analysis, Marginal,Benefit and Cost,Cost Benefit Analyses,Cost Benefit Data,Cost Utility Analysis,Cost-Benefit Analyses,Cost-Utility Analyses,Data, Cost-Benefit,Economic Evaluations,Evaluation, Economic,Marginal Analyses
D003937 Diagnosis, Differential Determination of which one of two or more diseases or conditions a patient is suffering from by systematically comparing and contrasting results of diagnostic measures. Diagnoses, Differential,Differential Diagnoses,Differential Diagnosis
D005340 Fibrinogen Plasma glycoprotein clotted by thrombin, composed of a dimer of three non-identical pairs of polypeptide chains (alpha, beta, gamma) held together by disulfide bonds. Fibrinogen clotting is a sol-gel change involving complex molecular arrangements: whereas fibrinogen is cleaved by thrombin to form polypeptides A and B, the proteolytic action of other enzymes yields different fibrinogen degradation products. Coagulation Factor I,Factor I,Blood Coagulation Factor I,gamma-Fibrinogen,Factor I, Coagulation,gamma Fibrinogen
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013924 Thrombophlebitis Inflammation of a vein associated with a blood clot (THROMBUS). Phlegmasia Alba Dolens,Dolens, Phlegmasia Alba,Thrombophlebitides

Related Publications

R D Hull, and G E Raskob, and J R LeClerc, and R M Jay, and J Hirsh
January 1985, Cleveland Clinic quarterly,
R D Hull, and G E Raskob, and J R LeClerc, and R M Jay, and J Hirsh
July 1999, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis,
R D Hull, and G E Raskob, and J R LeClerc, and R M Jay, and J Hirsh
January 1985, Acta medica Scandinavica,
R D Hull, and G E Raskob, and J R LeClerc, and R M Jay, and J Hirsh
September 1976, Surgery, gynecology & obstetrics,
R D Hull, and G E Raskob, and J R LeClerc, and R M Jay, and J Hirsh
August 1978, Lancet (London, England),
R D Hull, and G E Raskob, and J R LeClerc, and R M Jay, and J Hirsh
November 1987, Australasian radiology,
R D Hull, and G E Raskob, and J R LeClerc, and R M Jay, and J Hirsh
January 1997, Respiration; international review of thoracic diseases,
R D Hull, and G E Raskob, and J R LeClerc, and R M Jay, and J Hirsh
January 1995, Haemostasis,
R D Hull, and G E Raskob, and J R LeClerc, and R M Jay, and J Hirsh
October 2008, MMW Fortschritte der Medizin,
R D Hull, and G E Raskob, and J R LeClerc, and R M Jay, and J Hirsh
April 1986, Ugeskrift for laeger,
Copied contents to your clipboard!